[1]
2026. Comparative Assessment of the Metabolic Impact of Risperidone and Trifluoperazine in Drug-Naïve Psychotic Patients: A Prospective Observational Study. Central India Journal of Medical Research. 5, 02 (Aug. 2026), 68–73. DOI:https://doi.org/10.58999/cijmr.v5i02.370.